Ed Scura

Title: Ed Scura: Innovator in Vaccine Development

Introduction

Ed Scura is a notable inventor based in Potomac, MD (US), recognized for his contributions to the field of veterinary medicine and vaccine development. With a total of four patents to his name, Scura has made significant strides in creating innovative solutions for animal health.

Latest Patents

One of Scura's latest patents is a method of rapidly producing improved vaccines for animals. This method involves obtaining a nucleic acid molecule or fragment from a biological sample of an animal exposed to a pathogenic microorganism. A protective molecule is then prepared based on this nucleic acid, which is administered to animals at risk of exposure. This approach aims to elicit a protective response against the microorganism in the animal.

Another significant patent focuses on methods and compositions to protect aquatic invertebrates from disease. This patent describes various embodiments, including the preparation and delivery of dsRNA or antisense RNA targeting the nucleic acid of disease-causing microorganisms. The protective molecules can be delivered through different means, including replicon particles, ensuring that aquatic invertebrates receive the necessary protection from diseases.

Career Highlights

Ed Scura is currently associated with Harrisvaccines, Inc., a company dedicated to advancing vaccine technology for animals. His work at Harrisvaccines has positioned him as a key player in the development of innovative vaccine solutions.

Collaborations

Throughout his career, Scura has collaborated with notable colleagues, including Delbert Linn Harris and Kurt Iver Kamrud. These collaborations have further enhanced his research and development efforts in the field of veterinary vaccines.

Conclusion

Ed Scura's innovative work in vaccine development has made a significant impact on animal health. His patents reflect a commitment to advancing veterinary medicine through scientific research and collaboration.